Trial Profile
Exploratory, open-label, randomized, 2-period, 2-treatment, crossover study to investigate the effect of food on the pharmacokinetics of ACT-064992 in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary)
- Indications Eisenmenger complex; Glioblastoma; Idiopathic pulmonary fibrosis; Pulmonary arterial hypertension; Skin ulcer
- Focus Pharmacokinetics
- 14 Aug 2014 New trial record